Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

被引:0
|
作者
S Diem
B Kasenda
L Spain
J Martin-Liberal
R Marconcini
M Gore
J Larkin
机构
[1] Royal Marsden Hospital NHS Foundation Trust,Department of Medical Oncology
[2] Vall d’Hebron University Hospital,Department of Medical Oncology
[3] Vall d’Hebron Institute of Oncology (VHIO),Department of Medical Oncology
[4] Santa Chiara Hospital,undefined
来源
British Journal of Cancer | 2016年 / 114卷
关键词
melanoma; anti-PD-1; lactate dehydrogenase; marker; response; survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:256 / 261
页数:5
相关论文
共 50 条
  • [21] Anti-PD-1 tolerance after severe toxicity with ipilimumab therapy in metastatic melanoma patients.
    Brunot, Angelique
    Jeudy, Geraldine
    Tas, Mathieu
    Guillot, Bernard
    Kramkimel, Nora
    Mortier, Laurent
    Mansard, Sandrine
    Lebbe, Celeste
    Blom, Astrid
    Le Corre, Yannick
    Montaudie, Henri
    Prey, Sorilla
    Campillo-Gimenez, Boris
    Lesimple, Thierry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma
    Reddy, Swathi B.
    Possick, Jennifer D.
    Kluger, Harriet M.
    Galan, Anjela
    Han, Dale
    [J]. JOURNAL OF IMMUNOTHERAPY, 2017, 40 (08) : 307 - 311
  • [23] Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1
    Thomas, S.
    Laino, A.
    Sturm, R.
    Nufer, K.
    Lambie, D.
    Shepherd, B.
    Atkinson, V.
    Adams, L.
    Soyer, H. P.
    Schaider, H.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (05) : E176 - E177
  • [24] Correlating skin toxicity and steroid treatment with outcomes of anti-PD-1 therapy for patients with metastatic melanoma
    Quach, Henry T.
    Johnson, Douglas B.
    Dewan, Anna K.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB39 - AB39
  • [25] Safety and efficacy of anti-PD-1 antibodies in elderly patients with metastatic melanoma
    Rai, R.
    McQuade, J. L.
    Wang, D. Y.
    Park, J. J.
    Nahar, K.
    Sosman, J. A.
    Beckermann, K. E.
    Haydu, L. E.
    Lo, S.
    Rubinstein, S.
    Beckermann, K. E.
    McKean, M.
    Matthew, S.
    Guminski, A.
    Carlino, M. S.
    Davies, M.
    Johnson, D. B.
    Long, G. V.
    Menzies, A. M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [26] The importance of anti-PD-1 dosing in the treatment of patients with inoperable or metastatic melanoma
    Cybulska-Stopa, B.
    Czarnecka, A. M.
    Ostaszewski, K.
    Zietek, M.
    Piejko, K.
    Dziura, R.
    Galus, L.
    Ziolkowska, B. E.
    Kieszko, S.
    Kempa-Kaminska, N.
    Calik, J.
    Seredynska, J.
    Rogala, P.
    Drosik-Kwasniewska, A.
    Kaminska-Winciorek, G.
    Kubiatowski, T.
    Suwinski, R.
    Mackiewicz, J.
    Rutkowski, P.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S899 - S900
  • [27] The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson, Vyara
    Fessler, Jessica
    Bao, Riyue
    Chongsuwat, Tara
    Zha, Yuanyuan
    Alegre, Maria-Luisa
    Luke, Jason J.
    Gajewski, Thomas F.
    [J]. SCIENCE, 2018, 359 (6371) : 104 - +
  • [28] Commensal microbiota associated with anti-PD-1 efficacy in metastatic melanoma patients
    Matson, Vyara
    Fessler, Jessica
    Bao, Riyue
    Chongsuwat, Tara
    Zha, Yuanyuan
    Alegre, Maria-Luisa
    Luke, Jason
    Gajewski, Thomas
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [29] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Parakh, Sagun
    Park, John J.
    Mendis, Shehara
    Rai, Rajat
    Xu, Wen
    Lo, Serigne
    Drummond, Martin
    Rowe, Catherine
    Wong, Annie
    McArthur, Grant
    Haydon, Andrew
    Andrews, Miles C.
    Cebon, Jonathan
    Guminski, Alex
    Kefford, Richard F.
    Long, Georgina V.
    Menzies, Alexander M.
    Klein, Oliver
    Carlino, Matteo S.
    [J]. BRITISH JOURNAL OF CANCER, 2017, 116 (12) : 1558 - 1563
  • [30] Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases
    Park, J. J.
    Parakh, S.
    Mendis, S.
    Rai, R.
    Lo, S.
    Haydon, A.
    Andrews, M. C.
    Cebon, J.
    Guminski, A.
    Kefford, R.
    Long, G. V.
    Menzies, A. M.
    Klein, O.
    Carlino, M. S.
    [J]. ANNALS OF ONCOLOGY, 2016, 27